Durable Platelet Response in Immune Thrombocytopenia With Efgartigimod

(MedPage Today) -- NEW ORLEANS--An antibody fragment targeting neonatal Fc receptor (FcRn) achieved sustained platelet response in significantly more patients with primary immune thrombocytopenia (ITP) in a placebo-controlled trial.
Sustained...